CLINICAL_TRIALS
trial_result
· 2022-12-02
Clinical Trial Update: Tocilizumab Plus a Short Prednisone Taper for GCA [Phase 4]
Summary
A Phase 4 trial evaluating tocilizumab with a short prednisone taper for giant cell arteritis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Giant Cell Arteritis | Phase 4 | Status: COMPLETED | Results posted: 2022-12-02